Skip to results
1-4 of 4
Authors: Kenneth R. Carson
Sort by
Journal Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions Free
Charles L. Bennett and others
The Oncologist, Volume 26, Issue 8, August 2021, Pages e1418–e1426, https://doi.org/10.1002/onco.13713
Published: 12 March 2021
Journal Article
Real‐World Outcomes of Patients with Metastatic Non‐Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval Free
Sean Khozin and others
The Oncologist, Volume 24, Issue 5, May 2019, Pages 648–656, https://doi.org/10.1634/theoncologist.2018-0307
Published: 27 December 2018
Journal Article
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors Free
Jeremy M. O'Connor and others
The Oncologist, Volume 23, Issue 11, November 2018, Pages 1388–1390, https://doi.org/10.1634/theoncologist.2017-0673
Published: 16 July 2018
Journal Article
Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma Free
Tracey S. Beason and others
The Oncologist, Volume 18, Issue 10, October 2013, Pages 1074–1079, https://doi.org/10.1634/theoncologist.2013-0015
Published: 18 September 2013
Advertisement
Advertisement